IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway.

Source:http://linkedlifedata.com/resource/pubmed/id/21277902

Download in:

View as

General Info

PMID
21277902